Cell and gene therapy CDMO market forecast with growth insights
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Expected To Change From 2026 To 2030?
The size of the cell and gene therapy contract development and manufacturing organization (cdmo) market has shown exponential growth over the last few years. This market is projected to expand from $6.92 billion in 2025 to $8.85 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 27.8%. Historically, this expansion was driven by factors such as the increasing demand for outsourcing advanced therapy manufacturing, existing limitations in internal development capabilities, the rise of early-stage biotech companies, the broadening of orphan drug development, and an escalating requirement for specialized expertise.
The cell and gene therapy contract development and manufacturing organization (cdmo) market size is anticipated to undergo significant expansion in the coming years. It is projected to reach $21.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 24.6%. This projected growth throughout the forecast period stems from the increasing commercialization of gene-modified therapies, a rising requirement for flexible manufacturing capacity, the expansion of global cdmo partnerships, growing investment in cell therapy pipelines, and increasing regulatory approvals for advanced therapies. Prominent trends identified for this period include the broadening of end-to-end cdmo service offerings, a growing demand for commercial-scale manufacturing support, the rising adoption of advanced gene editing platforms, an increasing emphasis on accelerated development timelines, and enhanced integration of regulatory support services.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Important Drivers Are Guiding The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Growth?
The rising incidence of cancer diagnoses is anticipated to drive the future expansion of the cell and gene therapy contract development and manufacturing organization (CDMO) market. Cancer itself encompasses various conditions defined by the uncontrolled proliferation and spread of abnormal cells throughout the body. The increase in cancer cases can be attributed to an aging global populace, evolving lifestyle choices, environmental exposures, and advancements in detection methods. The cell and gene therapy contract development and manufacturing organization (CDMO) plays a role in mitigating cancer prevalence by developing and manufacturing cutting-edge, targeted treatments that improve both their efficacy and patient outcomes. For instance, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, an estimated 165,000 Australians were newly diagnosed with cancer, equivalent to over 450 cases each day, and approximately 55% of these diagnoses were among males. Thus, the escalating prevalence of cancer cases is a key factor boosting the growth of the cell and gene therapy contract development and manufacturing organization (CDMO) market.
How Is The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Broken Down By Segment Categories?
The cell and gene therapy contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy
2) By Phase: Phase 1, Phase 2, Phase 3
3) By Indication: Oncology, Infectious Diseases, Neurological Disorders, Rare Diseases, Other Indications
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, Plasmid DNA-Based Gene Therapy
2) By Gene-Modified Cell Therapy: CAR-T Cell Therapy, TCR-T Cell Therapy, NK Cell Therapy
3) By Cell Therapy: Stem Cell Therapy, Progenitor Cell Therapy, Immune Cell Therapy
What Trends Are Influencing The Evolution Of The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
Leading companies in the cell and gene therapy contract development and manufacturing organization (CDMO) market are prioritizing the expansion of their portfolio with advanced solutions, such as PluriMatrix technology, to enhance the scalability, efficiency, and quality of manufacturing cell-based products. PluriMatrix technology is a proprietary system specifically engineered for the large-scale production of cell-based products. This cutting-edge technology facilitates the industrial-scale 3D expansion of cells, ensuring high yields and consistent quality through an automated, fully controlled, and validated process. For instance, in January 2024, Pluri, an Israel-based biotech firm, launched PluriCDMO, a new business division that provides cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division includes a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility. As detailed in a company announcement, Pluri’s newly established division offers comprehensive services from early preclinical stages to late-stage clinical trials and commercialization, covering process and analytical development, scale-up, validation, logistics, automation, and regulatory-approved comparability studies. It leverages the company’s advanced PluriMatrix technology to deliver state-of-the-art cell therapy manufacturing services.
Which Players Are Present In The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Space?
Major companies operating in the cell and gene therapy contract development and manufacturing organization (cdmo) market are Lonza Group, Catalent Inc, Thermo Fisher Scientific Inc, Samsung Biologics Co Ltd, WuXi Biologics, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Oxford BioMedica Plc, Recipharm AB, Almac Group Ltd, KBI Biopharma, Rentschler Biopharma, Avid Bioservices Inc, Charles River Laboratories International Inc, VGXI Inc, Genezen Laboratories Inc, OmniaBio Inc, Pluri Inc, Cell and Gene Therapy Catapult, BioVectra Inc, Porton Advanced Solutions Ltd
Get The Full Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report:
Which Region Is The Leading Market For The Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the cell and gene therapy contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
